Regeneron Pharma upgraded by Leerink Partners with a new price target

2/5/25 7:03:51 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Leerink Partners upgraded Regeneron Pharma from Market Perform to Outperform and set a new price target of $834.00 from $762.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$REGN

Date	Price Target	Rating	Analyst
5/30/2025	$662.00	Outperform → Sector Perform	RBC Capital Mkts
5/30/2025	$580.00	Overweight → Equal Weight	Wells Fargo
5/14/2025	$700.00	Neutral → Buy	Citigroup
4/22/2025	$695.00	Overweight	Cantor Fitzgerald
2/5/2025	$762.00 → $834.00	Market Perform → Outperform	Leerink Partners
1/16/2025	$1130.00 → $738.00	Buy → Neutral	UBS
12/10/2024	$565.00	Underperform	BofA Securities
11/15/2024	$1150.00	Outperform	Wolfe Research